The medical device maker said it is unlikely to meet its full-year sales growth and adjusted earnings targets, and will ...
Despite making progress restoring global operations, the device maker said in a securities filing that it is unlikely to meet ...
The recent cyberattack on Boston Scientific is looking more serious than the medtech major first thought, with the company predicting a possible hit to its third-quarter and full-year results. | The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results